11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

27 trials found

diseases per page:

Showing 1 to 10 of 27 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003230-20-BE (EUCTR)	11/01/2021	07/10/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Mya ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	230	Phase 3	United States;Serbia;Spain;Russian Federation;United Kingdom;Italy;France;Czech Republic;Hungary;Can ...
2	EUCTR2020-003230-20-PL (EUCTR)	14/12/2020	30/09/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Mya ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	230	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...
3	EUCTR2020-003230-20-DE (EUCTR)	02/12/2020	14/09/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Mya ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...
4	EUCTR2020-003230-20-HU (EUCTR)	01/12/2020	01/10/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Mya ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	230	Phase 3	United States;Serbia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Czech Republic;Can ...
5	EUCTR2020-003230-20-GB (EUCTR)	30/11/2020	02/09/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Mya ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	230	Phase 3	United States;Serbia;Spain;Russian Federation;United Kingdom;Italy;France;Czech Republic;Hungary;Can ...
6	EUCTR2020-003230-20-DK (EUCTR)	17/11/2020	06/10/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Mya ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...
7	EUCTR2019-000969-21-DE (EUCTR)	20/04/2020	05/11/2019	A study to investigate the long-term safety, tolerability, and efficacy of rozanolixizumab in adult ...	A Randomized, Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Effi ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	276	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Bel ...
8	EUCTR2019-000969-21-PL (EUCTR)	12/04/2020	20/02/2020	A study to investigate the long-term safety, tolerability, and efficacy of rozanolixizumab in adult ...	A Randomized, Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Effi ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: rozanolixizumab	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	276	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Pol ...
9	EUCTR2019-000969-21-CZ (EUCTR)	24/02/2020	20/12/2019	A study to investigate the long-term safety, tolerability, and efficacy of rozanolixizumab in adult ...	A Randomized, Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Effi ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: rozanolixizumab	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	276	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Bel ...
10	EUCTR2019-000969-21-ES (EUCTR)	14/02/2020	11/11/2019	A study to investigate the long-term safety, tolerability, and efficacy of rozanolixizumab in adult ...	A Randomized, Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Effi ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: rozanolixizumab	UCB Biopharma SPRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	240	Phase 3	United States;Spain;Russian Federation;Italy;United Kingdom;France;Czech Republic;Hungary;Canada;Bel ...

First Previous1 2 3Next Last